CVRx (CVRX) Change in Receivables (2020 - 2026)
CVRx's (CVRX) quarterly Change in Receivables came in at -$1.6 million in Q1 2026, down 509.77% year-on-year from $380949.5 in Q1 2025, and down 163.56% quarter-over-quarter from $2.5 million in Q4 2025.
CVRx (CVRX) Change in Receivables (2020 - 2026) Analysis & Trends
CVRx's Change in Receivables history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 509.77% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was $92000.0, a 82.21% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 18.64% from the prior year.
- Change in Receivables slipped to -$1.6 million in Q1 2026 per CVRX's latest filing, from $2.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.5 million in Q4 2025 and bottomed at -$1.9 million in Q2 2025.
- The 5-year median for Change in Receivables is $292000.0 (2023), against an average of $384941.2.
- Biggest YoY gain for Change in Receivables was 945.11% in 2025; the steepest drop was 1774.77% in 2025.
- Year by year, Change in Receivables stood at $207000.0 in 2022, then jumped by 469.57% to $1.2 million in 2023, then tumbled by 80.07% to $235000.0 in 2024, then surged by 945.11% to $2.5 million in 2025, then plunged by 163.56% to -$1.6 million in 2026.
- Per Business Quant, the three latest CVRX Change in Receivables figures stand at -$1.6 million (Q1 2026), $2.5 million (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.56 Mn |
| Mar 31, 2026 | -1.56 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Mar 31, 2025 | -256,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 944,000.00 |
| Mar 31, 2024 | 944,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |